Nicholas Larus-Stone is head of the AI Agents team at Benchling, where he leads development of the company’s scientific agents and other AI-driven products. He joined Benchling following its acquisition of Sphinx Bio, the biotech startup he founded to apply AI to scientific data analysis and drug discovery. Earlier in his career, he was the first software engineer at Octant Bio and led the Machine Learning Infrastructure team at BenevolentAI. Nicholas also is the founder and president of Bits in Bio, a leading non-profit uniting innovators in software and life sciences.